Patrick Y. Tang

St. Paul's Hospital
Vancouver, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 185 publications

Phormia regina Fly as Vector for Ignatzschineria spp. Bacteremia in Persons Experiencing Homelessness, Canada, 2025.

Phormia regina Fly as Vector for Ignatzschineria spp. Bacteremia in Persons Experiencing Homelessness, Canada, 2025.

Journal: Emerging infectious diseases

Published: June 28, 2026

Routine SARS-CoV-2 Testing Frequency and Risk of Severe COVID-19: A Nationwide Population-Based Study.

Routine SARS-CoV-2 Testing Frequency and Risk of Severe COVID-19: A Nationwide Population-Based Study.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: May 08, 2026

Routine SARS-CoV-2 testing frequency and risk of severe COVID-19: A nationwide population-based study.

Routine SARS-CoV-2 testing frequency and risk of severe COVID-19: A nationwide population-based study.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: May 08, 2026

Overuse of a molecular infectious diarrhea panel in acute care: an opportunity for diagnostic stewardship.

Overuse of a molecular infectious diarrhea panel in acute care: an opportunity for diagnostic stewardship.

Journal: Antimicrobial stewardship & healthcare epidemiology : ASHE

Published: March 16, 2026

Reliability of Point-of-Care Vitamin D Testing for Use in Primary Health Care: A Comparative Evaluation with Established CLIA Platforms.

Reliability of Point-of-Care Vitamin D Testing for Use in Primary Health Care: A Comparative Evaluation with Established CLIA Platforms.

Journal: International journal of general medicine

Published: January 18, 2026

Evaluation of aztreonam/avibactam gradient test strip and aztreonam-ceftazidime/avibactam broth disk elution method for susceptibility testing of metallo-β-lactamase positive carbapenemase-producing bacteria.

Evaluation of aztreonam/avibactam gradient test strip and aztreonam-ceftazidime/avibactam broth disk elution method for susceptibility testing of metallo-β-lactamase positive carbapenemase-producing bacteria.

Journal: Diagnostic microbiology and infectious disease

Published: November 21, 2025

Carbapenemase-producing Klebsiella pneumoniae harbouring virulence-associated genes among war-affected children from the Gaza Strip.

Carbapenemase-producing Klebsiella pneumoniae harbouring virulence-associated genes among war-affected children from the Gaza Strip.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: October 16, 2025

Xpert MTB/RIF Ultra performance on bronchial specimens in diagnosing pulmonary tuberculosis in Vancouver, Canada.

Xpert MTB/RIF Ultra performance on bronchial specimens in diagnosing pulmonary tuberculosis in Vancouver, Canada.

Journal: Journal of medical microbiology

Published: June 06, 2025

Estimating SARS-CoV-2 infection incidence and detection rates: Demonstrating a novel surveillance method.

Estimating SARS-CoV-2 infection incidence and detection rates: Demonstrating a novel surveillance method.

Journal: Public health

Published: May 20, 2025

Comparative effectiveness of one versus two doses of COVID-19 vaccines in Qatar: Evidence of converging protection over time.

Comparative effectiveness of one versus two doses of COVID-19 vaccines in Qatar: Evidence of converging protection over time.

Journal: Vaccine

Published: May 08, 2025

Effectiveness and durability of a fourth dose of ancestral-strain mRNA vaccines against SARS-CoV-2 infection: a nationwide matched cohort study in Qatar.

Effectiveness and durability of a fourth dose of ancestral-strain mRNA vaccines against SARS-CoV-2 infection: a nationwide matched cohort study in Qatar.

Journal: Scientific reports

Published: March 31, 2025

Effectiveness of ChAdOx1 nCoV-19 (Vaxzevria) primary series vaccine against SARS-CoV-2 beta and delta variants: a nationwide study.

Effectiveness of ChAdOx1 nCoV-19 (Vaxzevria) primary series vaccine against SARS-CoV-2 beta and delta variants: a nationwide study.

Journal: BMC infectious diseases

Published: March 29, 2025

Showing 1-12 of 185

Last Updated: 09/26/2026